ReviewWorld journal of oncology2022
Primary Angiosarcoma of the Spleen: An Aggressive Neoplasm.
Review in World journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 12 citations in OpenAlex.
- Splenic angiosarcoma: a rare cause of the acute abdomen.Emergency radiology · 2026Review
- Ametabolic FDG-PET in Splenic Angiosarcoma: A Diagnostic Challenge.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Primary splenic angiosarcoma presenting with unexplained anemia in a young adult: a case report.Journal of medical case reports · 2026Article
- Primary splenic angiosarcoma with diffuse intrasinusoidal hepatic metastasis mimicking lymphoma: a diagnostic challenge.Clinical journal of gastroenterology · 2026Article
- Case Report of Primary Splenic Angiosarcoma in a Young Patient: A Very Rare and Challenging Disease.Case reports in surgery · 2026Article
- Characterization of CT and MRI findings in sclerosing angiomatoid nodular transformation of the spleen: novel discovery of peritumoral vascular signs.Quantitative imaging in medicine and surgery · 2025Article
- Splenic hamartoma mimicking angiosarcoma: A case report.World journal of clinical cases · 2025Article
- Spleen anomalies and lesions in CT and MRI: essentials for radiologists and clinicians-a pictorial review.Abdominal radiology (New York) · 2025Review
- Imaging and pathological characteristics of hepatosplenic EBV-positive inflammatory follicular dendritic cell sarcoma.Frontiers in oncology · 2025Article
- Pancytopenia Related to Splenic Angiosarcoma: A Case Report and Literature Review.Hematology reports · 2024Article
- Primary splenic angiosarcoma: a case series of a rare oncological entity and diagnostic challenge.Acta oncologica (Stockholm, Sweden) · 2024Article
- Metastatic splenic angiosarcoma presenting with anemia and bone marrow fibrosis mimicking primary myelofibrosis: A case report and literature review.Molecular and clinical oncology · 2024Article
- Application value ofFrontiers in oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary tumors of the spleen are rare, with an incidence rate of about 0.1%. These tumors could be benign, usually asymptomatic, or malignant which are usually symptomatic with abdominal pain being the most common symptom. Lymphoid neoplasms are the most common primary splenic tumors. Primary angiosarcoma is one of the extremely rare malignant vascular neoplasms of the spleen, which carries a dismal prognosis. It constitutes almost 7.4% of all primary malignant splenic neoplasms and is well known as an aggressive tumor with high local recurrence and distant metastasis rates. Overall survival is up to 12 months following diagnosis, regardless of management strategy. Due to the broad differential diagnosis of splenic tumors, this tumor is often forgotten, and is very challenging to diagnose early. Less than 300 cases of primary splenic angiosarcoma have been reported in the English literature. The main issue of this article is to review the current English literature to figure out the characteristic demographic features, clinical presentation, imaging findings and management of such tumors, in order to increase awareness of the treating physicians to improve diagnosis, management, as well as overall survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.